Johnson & Johnson Earnings: Analysis

On Tuesday, Johnson & Jonson reported its earnings more than doubled in the quarter. However, the shares didn’t move on the news. Citigroup analyst Matthew Dodds talks to NBR about what’s driving J&J’s earnings and why he thinks the stock is a buy.

This entry was posted in Earnings, Health Care. Bookmark the permalink.

Leave a Reply